Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has closed its acquisition of Contract Pharmaceuticals Limited Canada (“CPL” or the “Company”), a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms. Based in Mississauga, Ontario, Canada, CPL is an industry leader with longstanding relationships with 15 of the top 20 global pharmaceutical companies. The Company supports its customers through its FDA and Health Canada-registered facilities and sells into North America, the European Union, Japan, Australia, Mexico, Brazil and the Middle East.
Read the full article: Aterian Investment Partners Acquires Contract Pharmaceuticals Limited //
Source: https://www.businesswire.com/news/home/20240606726772/en/Aterian-Investment-Partners-Acquires-Contract-Pharmaceuticals-Limited